Hesse Pharmaceuticals Private Limited
About Hesse Pharmaceuticals Private Limited
Data last updated:
Hesse Pharmaceuticals Private Limited is a private limited company based in Pathankot, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U33100PB2020PTC051448.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sameera Dogra and Kanwal Krishan Dogra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No 31 Green Heaven Colony Village Mamoon, Pathankot, Punjab, India – 145001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.14 Lakh, a decline of 97% compared to the previous year. For the same year it recorded a net loss of ₹2.49 Lakh (net margin -218.5%) and EBITDA of -₹2.49 Lakh (EBITDA margin -218.5%). Revenue has declined at a compounded annual rate (CAGR) of 67% over three years.
Company details
Contact details
Hesse Pharmaceuticals Private Limited's registered office is in Pathankot, Punjab.
- Registered AddressHouse No 31 Green Heaven Colony Village Mamoon, Pathankot, Punjab, India – 145001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hesse Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Hesse Pharmaceuticals Private Limited, buy the company report.
Financials of Hesse Pharmaceuticals Private Limited
FY 2025 filings availableHesse Pharmaceuticals Private Limited reported revenue of ₹1.14 Lakh (down 97% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 67% over three years, including a 97% fall in the latest year. EBITDA fell 108% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.49 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.49 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -218.5% | ||||
| Net Profit Margin | -218.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hesse Pharmaceuticals Private Limited, buy the company report.
Board of directors of Hesse Pharmaceuticals Private Limited
Hesse Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sameera Dogra | Director | 21 Jul 2020 | 6 Years 3 Months | Current |
| Kanwal Krishan Dogra | Director | 21 Jul 2020 | 6 Years 3 Months | Current |
Peer comparison
Hesse Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anatolis Pharmaceuticals Private Limited | ₹1.16 Lakh (FY 2018) | Miraroad East, Maharashtra, India | ||||
| Srinaas Chemicals and Pharmaceuticals Private Limited | ₹1.15 Lakh (FY 2024) | Bibinagar, Telangana, India | ||||
| Hesse Pharmaceuticals Private Limitedthis company | ₹1.14 Lakh (FY 2025) | -₹2.49 Lakh | -218.5% | -97.0% | Pathankot, Punjab, India | |
| Oshid Pharmaceuticals Pvt Ltd | ₹1.14 Lakh (FY 2025) | -78.0% | Punjab, India | |||
| Cresscare Pharmaceuticals Private Limited | ₹1.13 Lakh (FY 2024) | 41.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Hesse Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Hesse Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hesse Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Hesse Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Hesse Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Kanwal Krishan Dogra was appointed as Director on 21 Jul 2020.
Frequently asked questions
Hesse Pharmaceuticals is an active private limited company based in Pathankot, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 July 2020 (6+ years old) and is registered under CIN U33100PB2020PTC051448.
Hesse Pharmaceuticals has 2 current directors:
- Sameera Dogra - Director
- Kanwal Krishan Dogra - Director
The latest financial statements of Hesse Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Hesse Pharmaceuticals is U33100PB2020PTC051448. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hesse Pharmaceuticals was incorporated on 21 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Hesse Pharmaceuticals by revenue are Anatolis Pharmaceuticals Private Limited, Srinaas Chemicals and Pharmaceuticals Private Limited, Oshid Pharmaceuticals Pvt Ltd, Cresscare Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kanwal Krishan Dogra was appointed as Director on 21 Jul 2020. Sameera Dogra was appointed as Director on 21 Jul 2020.
The registered office of Hesse Pharmaceuticals is at House No 31 Green Heaven Colony Village Mamoon, Pathankot, Punjab, India – 145001.
Hesse Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Hesse Pharmaceuticals can be reached at its registered office: House No 31 Green Heaven Colony Village Mamoon, Pathankot, Punjab, India – 145001.
Hesse Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Chandigarh.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
